Maintaining pharmacy accreditation requires a constant operational pulse to protect your bottom line. Treating compliance as a simple administrative hurdle can create significant risks for network access and long-term stability.
In a recent episode of the Over the Counter Podcast by Drug Topics, host Brian Nowosielski is joined by Mitch Lamb, PharmD, D2 Solutions’ Senior Director of Regulatory Operations and Services. With over 15 years of clinical and regulatory experience, Mitch explores the necessity of maintaining a constant pulse on accreditation compliance to protect both the bottom line and long-term business stability.
The conversation highlights why treating compliance as a simple administrative hurdle creates significant risks for network access. As the primary barrier of entry for limited-distribution drugs (LDDs), accreditation is more than a one-time milestone; it is an ongoing diligence requirement that ensures higher quality service and protects essential revenue streams.
Mitch also shares actionable strategies for navigating evolving standards, such as the transition from URAC 5.0 to 6.0, while leveraging technology like AccredComply to remain proactive.
Key takeaways from the episode:
- Network access is only possible with accreditation – a critical first to even begin business.
- Treating accreditation as a constant operational pulse is the only way to avoid catastrophic impacts to the bottom line.
- Documentation is 90% of the battle as accreditations require mountains of time-stamped data from across the organization. It’s the greatest opportunity for growth and the biggest risk for failure.
- Accreditation standards really are best practices. We’re in this to facilitate the best outcomes for the patient – full stop.
